The cancer nervous system rewiring oncology through neural disruption

Abstract

Cancer is increasingly recognized as a neurobiologically integrated entity rather than a mere collection of proliferative cells. This manuscript introduces the concept of the Cancer Nervous System (CNSy) ‒ a dynamic, self-sustaining neural network within the tumor microenvironment that governs oncogenic behavior. Malignant cells exploit adrenergic, cholinergic, and glutamatergic signaling pathways to regulate proliferation, immune evasion, and metastatic dissemination, mirroring physiological neural circuits. Evidence from neurofilament staining, spatial transcriptomics, and molecular profiling reveals de novo neurogenesis within tumors, suggesting an active interplay between cancer and the host nervous system. Beyond local interactions, tumors orchestrate systemic control over distant metastases through neurochemical signaling, exosomal communication, and inflammatory cytokine cascades. Disrupting this neuro-oncological axis presents a paradigm shift in cancer therapy. Pharmacological interventions targeting β-adrenergic signaling, such as β-blockers, have demonstrated potential in attenuating tumor progression and improving clinical outcomes. However, therapeutic strategies must evolve beyond conventional cytotoxic approaches to encompass neural modulation as a cornerstone of oncology. This perspective challenges the traditional view of cancer as a localized disease, reframing it as a neuromodulated malignancy with intrinsic connectivity to the nervous system. By integrating neuroscience into oncology, the CNSy model provides a novel framework for understanding tumor behavior and developing targeted therapies that disrupt neural contributions to malignancy. Recognizing the nervous system’s role in tumor dynamics not only advances our understanding of cancer biology but also unveils new opportunities for precision medicine